Atlas Trials

Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00079456 · COMPLETED

Trial details

NCT number
NCT00079456
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Start date
2004-02-01
Primary completion
2007-02-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.